We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Theravance Biopharma
TBPH
$877M
| $1.79M | ﹤0.01% |
176,173
-63,989
| -27% | -$600K |
|
2427
Sotera Health
SHC
$5.38B
| $1.78M | ﹤0.01% |
261,092
-15,980
| -6% | -$266K |
|
2428
CRA International
CRAI
$1.06B
| $1.77M | ﹤0.01% |
20,010
-4,265
| -18% | -$391K |
|
2429
Rayonier Advanced Materials
RYAM
$610M
| $1.77M | ﹤0.01% |
563,338
-108,485
| -16% | -$434K |
|
|
SOVO
2430
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $1.77M | ﹤0.01% |
124,666
+40,279
| +48% | +$589K |
|
2431
Mirum Pharmaceuticals
MIRM
$6.14B
| $1.76M | ﹤0.01% |
83,745
+44,942
| +116% | +$1.08M |
|
2432
Cass Information Systems
CASS
$743M
| $1.76M | ﹤0.01% |
50,677
-1,263
| -2% | -$45.4K |
|
|
WW
2433
DELISTED
WW International
WW
| $1.75M | ﹤0.01% |
444,809
+7,694
| +2% | +$46.6K |
|
|
FSP
2434
Franklin Street Properties
FSP
$46.8M
| $1.75M | ﹤0.01% |
664,178
-9,564
| -1% | -$31.5K |
|
2435
Tejon Ranch
TRC
$451M
| $1.75M | ﹤0.01% |
121,315
+527
| +0.4% | +$8.36K |
|
|
EBIX
2436
DELISTED
Ebix Inc
EBIX
| $1.74M | ﹤0.01% |
91,921
-4,602
| -5% | -$101K |
|
|
GES
2437
DELISTED
Guess Inc
GES
| $1.74M | ﹤0.01% |
118,465
+441
| +0.4% | +$7.88K |
|
|
ORGN
2438
DELISTED
Origin Materials
ORGN
| $1.74M | ﹤0.01% |
11,205
-181
| -2% | -$32.1K |
|
2439
OraSure Technologies
OSUR
$279M
| $1.74M | ﹤0.01% |
457,929
+70,822
| +18% | +$256K |
|
2440
SunCoke Energy
SXC
$797M
| $1.74M | ﹤0.01% |
298,630
-7,215
| -2% | -$48.5K |
|
2441
Solid Power
SLDP
$532M
| $1.73M | ﹤0.01% |
329,427
+141,150
| +75% | +$892K |
|
2442
Stagwell
STGW
$2.24B
| $1.73M | ﹤0.01% |
249,294
-17,025
| -6% | -$110K |
|
2443
Ennis
EBF
$564M
| $1.73M | ﹤0.01% |
86,014
+9,438
| +12% | +$199K |
|
|
LAND
2444
Gladstone Land Corp
LAND
$360M
| $1.73M | ﹤0.01% |
95,404
-2,257
| -2% | -$52.9K |
|
2445
MacroGenics
MGNX
$257M
| $1.72M | ﹤0.01% |
497,439
+170,615
| +52% | +$653K |
|
|
NSTG
2446
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.72M | ﹤0.01% |
134,723
-2,177
| -2% | -$30.2K |
|
|
PRVB
2447
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.72M | ﹤0.01% |
381,897
-739
| -0.2% | -$3.37K |
|
|
VZIO
2448
DELISTED
VIZIO Holding Corp.
VZIO
| $1.72M | ﹤0.01% |
196,722
-2,805
| -1% | -$28.2K |
|
|
AGTI
2449
DELISTED
Agiliti Inc
AGTI
| $1.72M | ﹤0.01% |
120,100
-24,586
| -17% | -$456K |
|
|
EGRX
2450
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.72M | ﹤0.01% |
64,919
-2,976
| -4% | -$109K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.